Publications by authors named "Zoe Hindle"

Claim this Profile
U
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
Thomas C Darton, Claire Jones, Christoph J Blohmke, Claire S Waddington, Liqing Zhou, Zoe Hindle

PLoS Negl Trop Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: a discussion of the adaptive licensure concept.
Roxana Rustomjee, Stephen Lockhart, Jacqueline Shea, P Bernard Fourie, Zoë Hindle

Tuberculosis (Edinb)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.
B D Kirkpatrick, Robin McKenzie, J Patrick O'Neill, Catherine J Larsson, A Louis Bourgeois, Zoë Hindle

Vaccine· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
Beth D Kirkpatrick, Katherine M Tenney, Catherine J Larsson, J Patrick O'Neill, Cassandra Ventrone, Zoe Hindle

J Infect Dis· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters.
Richard Stratford, Nicola D McKelvie, Nicky J Hughes, Emma Aldred, Claire Wiseman, Zoë Hindle

Infect Immun· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors.
Shahid A Khan, Richard Stratford, Tao Wu, Nicola Mckelvie, Trevor Bellaby, Zoe Hindle

Vaccine· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.
Zoë Hindle, Steven N Chatfield, Jo Phillimore, Matthew Bentley, Julie Johnson

Infect Immun· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis